(Q40764468)

English

Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study (English)

1 reference

Europe PubMed Central

23 September 2017

congenital disorder

0 references

0 references

object named as

Karen Casson

2

0 references

object named as

Anna Pierini

12

0 references

Babak Khoshnood

object named as

Babak Khoshnood

8

0 references

Kari Klungsøyr

9

object named as

Kari Klungsoyr

1 reference

Europe PubMed Central

23 September 2017

4

object named as

Marian Bakker

1 reference

Europe PubMed Central

23 September 2017

Marie-Claude Addor

5

object named as

Marie-Claude Addor

1 reference

Europe PubMed Central

23 September 2017

10

object named as

Vera Nelen

1 reference

Europe PubMed Central

23 September 2017

3

object named as

Ester Garne

1 reference

Europe PubMed Central

23 September 2017

15

object named as

Breidge Boyle

1 reference

Europe PubMed Central

23 September 2017

7

object named as

Miriam Gatt

1 reference

Europe PubMed Central

23 September 2017

Larraitz Arriola

6

object named as

Larraitz Arriola

1 reference

Europe PubMed Central

23 September 2017

13

object named as

Anke Rissmann

1 reference

Europe PubMed Central

23 September 2017

14

object named as

David Tucker

1 reference

Europe PubMed Central

23 September 2017

17

object named as

Helen Dolk

1 reference

Europe PubMed Central

23 September 2017

author name string

Anthony Wemakor

1

1 reference

Europe PubMed Central

23 September 2017

Mary O'Mahoney

11

1 reference

Europe PubMed Central

23 September 2017

Lolkje de Jong-van den Berg

16

1 reference

Europe PubMed Central

23 September 2017

publication date

7 July 2015

1 reference

Europe PubMed Central

23 September 2017

European Journal of Epidemiology

1 reference

Europe PubMed Central

23 September 2017

30

1 reference

Europe PubMed Central

23 September 2017

11

1 reference

Europe PubMed Central

23 September 2017

1187-1198

1 reference

Europe PubMed Central

23 September 2017

https://scigraph.springernature.com/pub.10.1007/s10654-015-0065-y

0 references

Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS).

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS).

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Effects of perinatal mental disorders on the fetus and child

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Prevalence and patterns of antidepressant drug use during pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Prevalence and predictors of antidepressant use in a cohort of pregnant women

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Outcomes of prenatal antidepressant exposure

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Fluoxetine use in early pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Antidepressant use during early pregnancy and the risk of congenital anomalies

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Selective serotonin reuptake inhibitors and malformations: case closed?

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Selective serotonin reuptake inhibitors (SSRIs) and heart defects: potential mechanisms for the observed associations

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Mouse 5-HT2B receptor-mediated serotonin trophic functions.

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Serotonin and its transporter on proliferation of fetal heart cells

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Antidepressant use in pregnancy and the risk of cardiac defects

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Paper 1: The EUROCAT network--organization and processes

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Valproic acid monotherapy in pregnancy and major congenital malformations

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Paper 6: EUROCAT member registries: organization and activities

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Paper 5: Surveillance of multiple congenital anomalies: implementation of a computer algorithm in European registers for classification of cases

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

An aetiological classification of birth defects for epidemiological research

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Guidelines for case classification for the National Birth Defects Prevention Study.

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

No adjustments are needed for multiple comparisons

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Validity of maternal and infant outcomes within nationwide Medicaid data

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Maternal stressful life events and risks of birth defects

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case-control study

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Use of specified critical periods of different congenital abnormalities instead of the first trimester concept

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Congenital Heart Defects in Europe: Prevalence and Perinatal Mortality, 2000 to 2005

1 reference

https://api.crossref.org/works/10.1007%2FS10654-015-0065-Y

21 January 2018

Paroxetine exposure during pregnancy and cardiac malformations

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teratogenicity of recently introduced medications in human pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing use of antidepressants in pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perinatal risks of untreated depression during pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lithium and pregnancy. A cohort study on manic-depressive women

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine in the first trimester and the prevalence of congenital malformations

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective serotonin reuptake inhibitors and adverse pregnancy outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant drug exposure during pregnancy. CZTIS small prospective study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Birth outcomes in pregnant women taking fluoxetine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prescription drug use in pregnancy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microcephaly: an epidemiologic analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of antidepressant medications during pregnancy: a multisite study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Lifetime prevalence of mental disorders in general adult population. Results of TACOS study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26148560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10654-015-0065-Y

1 reference

Europe PubMed Central

23 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40764468&oldid=2052852940"